STOCK TITAN

Exact Sciences to Participate in March Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Exact Sciences (Nasdaq: EXAS), a leading cancer screening and diagnostic tests provider, has announced its management team's upcoming participation in two major investor conferences in March 2025.

The company will participate in a fireside chat at the TD Cowen Health Care Conference in Boston on Monday, March 3, 2025, at 10:30 a.m. ET. Additionally, they will deliver a presentation at the Raymond James Institutional Investors Conference in Orlando on Tuesday, March 4, 2025, at 1:05 p.m. ET.

Investors can access the webcasts of both events through the investor relations section of Exact Sciences' website at www.exactsciences.com.

Exact Sciences (Nasdaq: EXAS), un fornitore leader di screening e test diagnostici per il cancro, ha annunciato la prossima partecipazione del suo team di gestione a due importanti conferenze per investitori nel marzo 2025.

La società parteciperà a un fireside chat alla TD Cowen Health Care Conference a Boston lunedì 3 marzo 2025, alle 10:30 ET. Inoltre, presenteranno una presentazione alla Raymond James Institutional Investors Conference a Orlando martedì 4 marzo 2025, alle 13:05 ET.

Gli investitori possono accedere alle trasmissioni web di entrambi gli eventi attraverso la sezione relazioni con gli investitori del sito web di Exact Sciences all'indirizzo www.exactsciences.com.

Exact Sciences (Nasdaq: EXAS), un proveedor líder de pruebas de detección y diagnóstico del cáncer, ha anunciado la próxima participación de su equipo de gestión en dos importantes conferencias para inversores en marzo de 2025.

La empresa participará en un fireside chat en la TD Cowen Health Care Conference en Boston el lunes 3 de marzo de 2025, a las 10:30 a.m. ET. Además, realizarán una presentación en la Raymond James Institutional Investors Conference en Orlando el martes 4 de marzo de 2025, a la 1:05 p.m. ET.

Los inversores pueden acceder a las transmisiones web de ambos eventos a través de la sección de relaciones con inversores del sitio web de Exact Sciences en www.exactsciences.com.

엑잭트 사이언스 (Nasdaq: EXAS), 주요 암 검진 및 진단 테스트 제공업체가 2025년 3월에 열리는 두 개의 주요 투자자 회의에 경영진이 참석할 것이라고 발표했습니다.

회사는 2025년 3월 3일 월요일 오전 10시 30분 ET에 보스턴에서 열리는 TD Cowen Health Care Conference에서 파이어사이드 채팅에 참여합니다. 또한, 2025년 3월 4일 화요일 오후 1시 5분 ET에 올랜도에서 열리는 Raymond James Institutional Investors Conference에서 발표를 진행할 예정입니다.

투자자는 Exact Sciences 웹사이트의 투자자 관계 섹션을 통해 두 행사 모두의 웹캐스트에 접근할 수 있습니다: www.exactsciences.com.

Exact Sciences (Nasdaq: EXAS), un fournisseur de premier plan de tests de dépistage et de diagnostic du cancer, a annoncé la prochaine participation de son équipe de direction à deux grandes conférences pour investisseurs en mars 2025.

L'entreprise participera à un fireside chat lors de la TD Cowen Health Care Conference à Boston le lundi 3 mars 2025, à 10h30 ET. De plus, ils réaliseront une présentation lors de la Raymond James Institutional Investors Conference à Orlando le mardi 4 mars 2025, à 13h05 ET.

Les investisseurs peuvent accéder aux webdiffusions des deux événements via la section relations avec les investisseurs du site web d'Exact Sciences à l'adresse www.exactsciences.com.

Exact Sciences (Nasdaq: EXAS), ein führender Anbieter von Krebsfrüherkennungs- und Diagnosetests, hat die bevorstehende Teilnahme seines Managementteams an zwei wichtigen Investorenkonferenzen im März 2025 angekündigt.

Das Unternehmen wird am Montag, den 3. März 2025, um 10:30 Uhr ET an einem Fireside Chat auf der TD Cowen Health Care Conference in Boston teilnehmen. Zudem werden sie am Dienstag, den 4. März 2025, um 13:05 Uhr ET eine Präsentation auf der Raymond James Institutional Investors Conference in Orlando halten.

Investoren können die Webcasts beider Veranstaltungen über den Bereich Investor Relations auf der Website von Exact Sciences unter www.exactsciences.com abrufen.

Positive
  • None.
Negative
  • None.

MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

  • TD Cowen Health Care Conference, Boston
    Fireside chat on Monday, March 3, 2025 at 10:30 a.m. ET
  • Raymond James Institutional Investors Conference, Orlando
    Presentation on Tuesday, March 4, 2025 at 1:05 p.m. ET

The webcasts can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Derek Leckow

Exact Sciences Corp.

investorrelations@exactsciences.com

608-893-0009

Source: Exact Sciences Corp.

FAQ

When is Exact Sciences (EXAS) presenting at the TD Cowen Health Care Conference in 2025?

Exact Sciences will participate in a fireside chat at the TD Cowen Health Care Conference in Boston on Monday, March 3, 2025, at 10:30 a.m. ET.

What time is Exact Sciences' (EXAS) presentation at the Raymond James Conference in March 2025?

Exact Sciences will present at the Raymond James Institutional Investors Conference in Orlando on Tuesday, March 4, 2025, at 1:05 p.m. ET.

How can investors watch Exact Sciences' (EXAS) March 2025 conference presentations?

Investors can access the webcasts through the investor relations section of Exact Sciences' website at www.exactsciences.com.

Which investor conferences is Exact Sciences (EXAS) attending in March 2025?

Exact Sciences is attending the TD Cowen Health Care Conference in Boston and the Raymond James Institutional Investors Conference in Orlando in March 2025.

Exact Sciences Corp

NASDAQ:EXAS

EXAS Rankings

EXAS Latest News

EXAS Stock Data

9.02B
183.02M
1.02%
101.67%
5.56%
Diagnostics & Research
Services-medical Laboratories
Link
United States
MADISON